0001375151-19-000048.txt : 20190402
0001375151-19-000048.hdr.sgml : 20190402
20190402171220
ACCESSION NUMBER: 0001375151-19-000048
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190329
FILED AS OF DATE: 20190402
DATE AS OF CHANGE: 20190402
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HAWLEY ROGER
CENTRAL INDEX KEY: 0001257386
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34962
FILM NUMBER: 19726196
MAIL ADDRESS:
STREET 1: 3655 NOBEL DRIVE, SUITE 260
CITY: SAN DIEGO
STATE: CA
ZIP: 92122
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ZOGENIX, INC.
CENTRAL INDEX KEY: 0001375151
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 205300780
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5858 HORTON STREET, #455
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: (510) 550-8300
MAIL ADDRESS:
STREET 1: 5858 HORTON STREET, #455
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
FORMER COMPANY:
FORMER CONFORMED NAME: ZOGENIX INC
DATE OF NAME CHANGE: 20060911
4
1
wf-form4_155423952274020.xml
FORM 4
X0306
4
2019-03-29
0
0001375151
ZOGENIX, INC.
ZGNX
0001257386
HAWLEY ROGER
C/O ZOGENIX, INC.
5959 HORTON STREET, SUITE 500
EMERYVILLE
CA
94608
1
0
0
0
Common Stock
2019-03-29
4
M
0
5000
20
A
15575
D
Common Stock
2019-03-29
4
S
0
5000
55
D
10575
D
Common Stock
2019-03-29
4
M
0
15700
33.92
A
26275
D
Common Stock
2019-03-29
4
S
0
15700
55
D
10575
D
Stock Option (Right to Buy)
20.0
2019-03-29
4
M
0
5000
0
D
2019-09-01
Common Stock
5000.0
2500
D
Stock Option (Right to Buy)
33.92
2019-03-29
4
M
0
15700
0
D
2021-03-01
Common Stock
15700.0
20624
D
The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
The Option was granted on September 1, 2009 and vests in a series of twenty-four (24) successive, equal monthly installments measured from the date of grant, subject to the Reporting Person's continued service to the Company on each vesting date.
The Option was granted on March 1, 2011 and vests in a series of forty-eight (48) successive, equal monthly installments measured from the date of grant, subject to the Reporting Person's continued service to the Company on each vesting date.
Effective March 31, 2019, Mr. Hawley resigned from the Company's Board of Directors. As a result, Mr. Hawley is no longer subject to Section 16 in connection with his transactions in the equity securities of the Company and therefore will no longer report any such transactions on Form 4 or Form 5.
/s/ Thomas Doyle, Attorney-in-fact for Roger Hawley
2019-04-02